IBB ETF holdings (NASDAQ) - Page 6 | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

SRPT Sarepta Therapeutics, Inc. 12.9 M 718.9 K 0.1%

SNDX Syndax Pharmaceuticals, Inc. 12.5 M 571.7 K 0.1%

TRVI Trevi Therapeutics, Inc. 12.3 M 658.2 K 0.1%

RXRX Recursion Pharmaceuticals, Inc. 12.2 M 3.3 M 0.1%

ZLAB Zai Lab Ltd. 12.0 M 633.5 K 0.1%

AMLX Amylyx Pharmaceuticals, Inc. 11.8 M 658.5 K 0.1%

MLYS Mineralys Therapeutics, Inc. 11.6 M 431.3 K 0.1%

FTRE Fortrea Holdings, Inc. 11.5 M 663.6 K 0.1%

TSHA Taysha Gene Therapies, Inc. 11.5 M 1.7 M 0.1%

MBX MBX Biosciences, Inc. 11.5 M 207.8 K 0.1%

STOK Stoke Therapeutics, Inc. 11.5 M 350.0 K 0.1%

IOVA Iovance Biotherapeutics, Inc. 11.4 M 2.7 M 0.1%

NVCR Novocure Ltd. 11.1 M 734.7 K 0.1%

GRFS Grifols SA 11.0 M 1.6 M 0.1%

ATAI AtaiBeckley, Inc. 10.9 M 2.1 M 0.1%

ABSI Absci Corp. 10.9 M 942.5 K 0.1%

CMPS Compass Pathways plc 10.8 M 764.9 K 0.1%

URGN UroGen Pharma Ltd. 10.7 M 290.4 K 0.1%

NVAX Novavax, Inc. 10.5 M 1.1 M 0.1%

TYRA Tyra Biosciences, Inc. 10.0 M 314.5 K 0.1%

1
...
4
5
6
7
8
9
...
13

Notizie

UBS elenca 5 motivi chiave per cui le azioni biotech a media capitalizzazione dovrebbero performare bene nel 2026